Prescription drug · NDA
Sodium Thiosulfate NDC 60267-705
Sodium thiosulfate 250 mg/mL · Injection, Solution · Intravenous · Hope Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60267-705-50 | 60267070550 | 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50)Marketed from Feb 14, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Thiosulfate
- Generic name (nonproprietary)
- sodium thiosulfate
- Active ingredients
- Sodium thiosulfate — 250 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Hope PharmaceuticalsNDC labeler code 60267
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 203923
- Marketing start
- Listing expires
- Identifiers
- Product ID 60267-705_4c4f587f-fb6f-4ce3-a09e-2a6a589b4d2bSPL ID 4c4f587f-fb6f-4ce3-a09e-2a6a589b4d2bSPL set ID 82f55408-2de9-463d-85e8-b39c3b259f0bRxCUI 237832UNII HX1032V43M
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N460267070550followed by a unit qualifier and the quantityPackage 60267-0705-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sodium Thiosulfate Injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. When the diagnosis of cyanide poisoning is uncertain, the potential risks associated with Sodium Thiosulfate Injection should be carefully weighed against the potential benefits, especially if the patient is not in extremis. Sodium Thiosulfate Injection, an antidote, is indicated for sequential use with sodium nitrite for treatment of acute cyanide poisoning that is judged to be serious or life-threatening. ( 1 ) Use with caution if the diagnosis of cyanide poisoning is uncertain. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 60267-705
- What is NDC 60267-705?
- 60267-705 is the product NDC for Sodium Thiosulfate, Sodium thiosulfate 250 mg/mL injection, solution, listed with the FDA by Hope Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sodium Thiosulfate.
- What is the active ingredient?
- Sodium thiosulfate.
- Who is the labeler?
- Hope Pharmaceuticals, NDC labeler code 60267. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sodium Thiosulfate?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.